Sales and Marketing

Showing 15 posts of 11527 posts found.

Stephen Stamp joins board at Eusa Pharma

September 7, 2010 Sales and Marketing Eusa Pharma, appointment, sales and marketing

Transatlantic specialty company Eusa Pharma has appointed Stephen Stamp to its board as an independent non-executive director. Stephen has previously …

Pressure mounts on GSK over Avandia

September 6, 2010 Sales and Marketing Avandia, GlaxoSmithKline

GlaxoSmithKline is under mounting pressure this week as calls intensify for its type II diabetes drug Avandia to be withdrawn …

Parallel trading restricting medicine access, says ABPI

September 6, 2010 Sales and Marketing parallel trade, pharmacists, supply chain

The ABPI has blamed parallel trading by a minority of pharmacists as the root cause of the current medicines shortage …

Olivier Bohuon takes post at Pierre Fabre

September 6, 2010 Sales and Marketing Pierre Fabre, appointment, sales and marketing

French pharma company Pierre Fabre has officially appointed Olivier Bohuon to take over from Jean-Pierre Garnier as chief executive. Olivier’s …

Sanofi’s Multaq in pole position for AF market

September 6, 2010 Sales and Marketing Multaq, Sanofi-Aventis, atrial fibrilation

New European Society of Cardiology guidelines on treating atrial fibrillation (AF) include a recommendation for Sanofi-Aventis’ Multaq. The endorsement is …

Pradaxa, Xarelto and apixaban vie for attention

September 6, 2010 Research and Development, Sales and Marketing Pradaxa, Xarelto, apixaban, atrial fibrilation

New data has intensified the competition between three rival would-be cardiology blockbusters. Boehringer Ingelheim’s Pradaxa (dabigatran) and Bayer’s Xarelto (rivaroxaban) …

Watchdog resignation forced ‘to appease pharma’

September 6, 2010 Sales and Marketing Germany, IQWIG

The head of Germany’s medicines cost-effectiveness watchdog was forced to resign because he was a vocal critic of the pharma …

Roche set for jobs cuts from 2011

September 3, 2010 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, job cuts

Roche has confirmed it will take wide-ranging steps to reduce costs, following local reports the Swiss pharma firm was poised …

AZ’s Seroquel extends European licence

September 3, 2010 Sales and Marketing AstraZeneca, Seroquel

AstraZeneca’s controversial anti-psychotic drug Seroquel has been given the green light in Europe as an add-on treatment for serious depressive …

Merck wins double approval in Europe

September 3, 2010 Sales and Marketing Brinavess, Merck & Co, Syncrest, merck sharp and dohme

European regulators have given the green light for two of Merck & Co’s new drugs, licensing its anti-psychotic treatment Sycrest …

Industry supports Australia’s new price deal

September 3, 2010 Sales and Marketing Australia, global pricing, price cuts

Australia’s pharmaceutical industry is urging the country’s legislators to pass a new medicines pricing bill that aims to save Aus$1.9 …

Abbott’s Meridia ‘increases heart attack risk’

September 2, 2010 Sales and Marketing Abbott, Meridia, drug safety

Abbott’s weight-loss drug Meridia increases the risk of stroke and heart attack in patients with heart disease, according a study …

Genzyme available for ‘fair value’, says Termeer

September 2, 2010 Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Genzyme’s chief executive Henri Termeer has said his company could be for sale to Sanofi-Aventis if it offers a ‘fair …

Cephalon chairman takes leave of absence

September 2, 2010 Research and Development, Sales and Marketing Cephalon, appointment, research and development, sales and marketing

Cephalon’s chairman and chief executive Frank Baldino Jr is taking a medical leave of absence with immediate effect. The company …

EMA to assess GSK flu vaccine for narcolepsy link

September 1, 2010 Research and Development, Sales and Marketing GlaxoSmithKline, Pandemrix, h1n1

The European Medicines Agency has launched a review of GlaxoSmithKline’s influenza vaccine Pandemrix. The European Commission asked the EMA to …
The Gateway to Local Adoption Series

Latest content